Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-57
Closed -$3.73K – 1095
2021
Q2
$3.73K Hold
57
– – ﹤0.01% 787
2021
Q1
$3.63K Buy
+57
New +$2.96K ﹤0.01% 639

Exane Derivatives's TLND Position: Q3 2021 in Review

Exane Derivatives sold out of Talend (TLND) in Q3 2021, closing a stake of 57 shares — an estimated $3.73K sold.

Exane Derivatives first reported a position in TLND in Q1 2021 and held it in 2 quarters. The position peaked at $3.73K in Q2 2021. 0 funds tracked by Wall St. Rank hold TLND as of Q3 2021.

  • Exane Derivatives reported no remaining Talend position as of Q3 2021 after selling out during the quarter.
  • Exane Derivatives sold 57 Talend shares in Q3 2021, an estimated $3.73K.
  • Exane Derivatives first reported a position in Talend in Q1 2021 and held it in 2 quarters.
  • Exane Derivatives's Talend position peaked at $3.73K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Talend as of Q3 2021.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.